(Q44078540)

29 November 2017

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer (English)

1 reference

29 November 2017

Lucinda J. Billingham

1

1 reference

29 November 2017

Bathers S

2

1 reference

29 November 2017

Burton A

3

1 reference

29 November 2017

Bryan S

4

1 reference

29 November 2017

Cullen MH

5

1 reference

29 November 2017

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

37

1 reference

29 November 2017

2

1 reference

29 November 2017

219-225

1 reference

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

The hospital costs of treating lung cancer in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900042-9

7 January 2021

10.1016/S0169-5002(02)00042-9

Identifiers

DOI

1 reference

29 November 2017

1 reference